In this article, Lally and colleagues present the results of an open-label trial of the anti-interleukin (IL)-6 receptor agent tocilizumab in 10 patients with isolated polymyalgia rheumatica (PMR).

Background: Polymyalgia rheumatica is one of the most common inflammatory rheumatologic conditions in older adults. Other inflammatory rheumatologic disorders are associated with an excess risk of ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved sarilumab for the treatment of polymyalgia rheumatica in adults who have experienced an ...

The approval was based on data from a phase 3 study which included adults with steroid-resistant active PMR who flared on at least 7.5mg per day of prednisone or equivalent during taper. The Food and ...

Please provide your email address to receive an email when new articles are posted on . Recent data demonstrated, however, the utility of ultrasonography to detect biceps tenosynovitis and subdeltoid ...

Polymyalgia rheumatica (PMR) is a systemic inflammatory disorder that predominantly affects individuals over the age of 50. It is characterised by pain and stiffness in the shoulder and hip girdles, ...

Tofacitinib (Xeljanz) appeared highly effective against polymyalgia rheumatica (PMR) in a small single-arm trial, researchers said, suggesting another potential alternative to long-term ...

Keep abreast with the latest news related to Polymyalgia Rheumatica there are 8 news items on Polymyalgia Rheumatica that covers updates, breakthroughs and in-depth reports. We provide you with a free ...

Polymyalgia rheumatica (PMR) is a rheumatic disease characterized by recurrent inflammatory episodes. PMR is usually seen in Caucasians living in Northern Europe and North America. The condition ...

The US Food and Drug Administration (FDA) approved sarilumab (Kevzara) today for the treatment of polymyalgia rheumatica (PMR) in adults who have had an inadequate response to corticosteroids or could ...

Adenovirus: A virus that causes respiratory infections. Anemia: This is a condition that develops when the blood lacks healthy red blood cells (RBC) or hemoglobin, which is responsible for ...